The Effect of Vascular Wall Injury on the Regulation of Cell Cycle and Inflammation Marker Proteins
Loading...
Authors
Virupannavar, Shanti
Issue Date
2007
Type
Thesis
Language
en_US
Keywords
Alternative Title
Abstract
The objective of this study was to investigate the effect of vascular wall injury
through stent oversizing on the regulation of cell cycle proteins and inflammation
markers. In particular, the amounts of cell cycle regulatory proteins, p27 and FKBP12,
and inflammation marker, PCNA, were assessed in high injury, low injury and control
treatment groups. Cypher© sirolimus eluting stents and Bx Velocity© (balloon
expandable) bare metal stents were implanted in four Sus scrofa at high injury (30%
balloon to artery ratio, or BAR), and in four swine at low injury (15% BAR). It was
hypothesized that PCNA and FKBP12 would be upregulated and p27 would be
downregulated in the high injury treatment group as compared to the low injury and
control treatment groups.
Arterial tissue samples were obtained from stented vessels and from non-stented
control vessels, three days following stent implantation. Fallowing determination of
protein concentration in the sample, SDS-PAGE and Western Blot analysis were
performed. For statistical analysis, protein values were normalized initially to actin, as a
loading control, and then to untreated (non-stented) controls, to account for variation
among the pigs.
No significant differences in p27 or PCNA expression were found among high
injury, low injury or untreated models. For FKBP12, however, we found that as vessel
wall trauma became more severe due to stent oversizing, the amount of FKBP 12
increased from 1.807±1.473 to 9.952±13.963 (p=0.0396). This suggests that high vessel
wall injury leads to cell cycle hyperactivation and potentially contributes to increased
intimal thickening.
Description
iii, 34 p.
Citation
Publisher
License
U.S. copyright laws protect this material. Commercial use or distribution of this material is not permitted without prior written permission of the copyright holder. All rights reserved.